FDA
-
-
-
-
-
-
-
INVIVYD completes enrollment in Phase 3 COVID antibody trial
-
-
-
-
-
-
-
Invivyd to Participate in Upcoming Investor Events
-
-
-
-
-
-
-
Invivyd expands COVID-19 study, develops measles antibody candidate
-
-
-
-
-
-
-
Invivyd to Host Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update Conference Call on March 5, 2026
-
-
-
-
-
-
-
Invivyd Announces Partnership with World Champion Skier Lindsey Vonn to Educate Americans on Antibodies and Disease Prevention
-
-
-
-
-
-
-
Invivyd launches phase 3 trial for COVID antibody treatment VYD2311
-
-
-
-
-
-
-
Invivyd announces public offering of common stock
-
327,906 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

